Print

Universal Influenza Immunization Program (UIIP)

The following provides information about the Ontario Ministry of Health and Long-Term Care’s (the ministry’s) Universal Influenza Immunization Program (UIIP) for the 2017-2018 influenza season. The official launch of the UIIP will occur on October 23rd, 2017. Influenza immunization for the general population through community-based influenza immunization clinics will begin on or after the UIIP launch date. As in previous years, immunization of high priority groups should begin as soon as influenza vaccine is available.

Recommended Influenza Vaccine Recipients

All individuals aged 6 months or older who live, work or attend school in Ontario are eligible and  are recommended to receive the publicly funded influenza vaccine in Ontario (provided that they have no contraindications to the vaccine).

Individuals at high risk of influenza-related complications or more likely to require hospitalization:

  • Adults or children with chronic health conditions as follows:
  • Individuals capable of transmitting influenza to those at high risk:
  • In addition, the ministry strongly recommends that swine and poultry industry workers receive influenza immunization as early as possible.

  • The publicly funded influenza vaccines available through the 2017/18 UIIP are listed in the table below:

    Trivalent Inactivated Vaccines (TIVs)* Fluviral® Influvac® Agriflu®
    Dosage 0.5mL 0.5mL 0.5mL
    Format Multi-dose vial Pre-filled syringes Multi-dose vial
    Administration Route Intramuscular Injection Intramuscular Injection Intramuscular Injection

    Age Indications
    (per product monograph)

    6 months 3 years 6 months
    Potential Allergens

    Egg Protein^ Formaldehyde
    Thimerosal

    Egg Protein^ Chicken Protein
    Formaldehyde
    Gentamicin

    Egg Protein^
    Thimerosal
    Neomycin
    Kanamycin
    Formaldehyde

    Post-Puncture Shelf Life 28 days N/A 28 days

    Package Dimensions
    in cm
    (l x w x h)

    3 x 3 x 7 18.8 x 15.2 x 1.7 3x7x3
    Quadrivalent Inactivated
    Vaccines (QIVs)
    FluLaval Tetra® Fluzone® Quadrivalent ~
    Dosage 0.5mL 0.5mL
    Format Multi-dose vial

    Multi-dose vial
    Pre-filled
    syringe

    Administration Route Intramuscular Injection Intramuscular Injection

    Age Indications
    (per product monograph)

    6 months 6 months
    Potential Allergens

    Egg Protein^ Formaldehyde
    Thimerosal

    Multi-dose:

    Egg Protein^ Formaldehyde
    Thimerosal

    Pre-filled:

    Egg Protein
    Formaldehyde

    Post-Puncture Shelf Life 28 days

    Multi-dose:
    Up to expiry date indicated
    on vial label

    Pre-filled:
    N/A

    Package Dimensions in cm
    (l x w x h)

    3 x 3 x 6 Multi-dose:
    3.6 x 2.9 x 6

    Pre-filled:
    10.4 x 8.9 x 3.8
    Quadrivalent - Live Attenuated Vaccine (Q-LAIV)** Flumist® Quadrivalent
    Dosage 0.2mL
    (0.1mL in each nostril)
    Format Pre-filled single use sprayer
    Administration Route Intranasal spray

    Age Indications
    (per product monograph)

    2 to 59 years
    Potential Allergens

    Arginine
    Egg Protein^
    Gelatin
    Gentamicin

    Post-Puncture Shelf Life N/A

    Package Dimensions in cm
    (l x w x h)

    10.6 x 17.6 x 2.9

    Note: Additional information is available in the product monograph
    * Unless specifically requested, the TIVs are primarily targeted to adults 18 years of age and older.
    **The National Advisory Committee on Immunization (NACI) has removed the preferential recommendation for the use of live attenuated vaccine in children 2 to under 6 years of age
    ^ NACI has concluded that egg allergic individuals may be vaccinated against influenza using live attenuated influenza vaccine (see ADDENDUM – LAIV Use in Egg Allergic Individuals-Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2017-18.
    ~Fluzone ® Quadrivalent and Fluzone High Dose ® are two different products. Please see product monographs for further information.

    Important Notes:

    Vaccines for Specific Age Groups:

    Recommended Vaccine
    Age Group TIV Influvac TIV Fluviral TIV Agriflu QIV FluLaval QIV Fluzone Q-LAIV Flumist
    6 to 23 months
    Yes
    Yes
    2 to17 years
    Yes
    Yes
    Yes
    18 years
    Yes
    Yes
    Yes
    Alternative Vaccine (if requested or if recommended vaccine is not available)
    Age Group TIV Influvac TIV Fluviral TIV Agriflu QIV FluLaval QIV Fluzone Q-LAIV Flumist
    6 to 23 months
    Yes
    Yes
         
    2 to17 years
    Yes (3 years)*
    Yes
    Yes
         
    18 years
         

    Note:

    *Influvac is indicated for those 3 years of age and older in the product monograph

    Influenza Vaccine Ordering

    Health Care Providers Location Order vaccine from
    All providers with the exception of pharmacists outside Toronto
    (not within the "M" potal code)
    Local public health unit by using the Influenza Vaccine Order Form for the UIIP
    All providers within Toronto
    (within the "M" area code)
    Ontario Government Pharmaceutical and Medical Supply Service (OGPMSS) by faxing the Influenza Vaccine Order Form for the UIIP to 416-327-0818

    Pharmacists

    outside Toronto
    (not within the "M" potal code)
    Refer to Pharmacies with Trained Pharmacists section below for details on vaccine ordering

    The TIV products (Influvac®, Agriflu® and Fluviral®) and QIV products (FluLaval Tetra® and Fluzone® Quadrivalent®) will be distributed based on availability (requests for specific TIV products or QIV products are not permitted). Each TIV product and each QIV product are considered equivalent with respect to their approved indications for use. Please consult your local public health unit to determine vaccine availability for your clinic.

    Influenza vaccine is received in Ontario intermittently throughout late September and October, and distributed throughout influenza season. As in previous years, vaccine distribution for the 2017/2018 influenza season will begin around late September to late October for the immunization of high priority groups . Community-based influenza immunization clinics for the general population will begin when the UIIP is officially launched in late-October:

    All required fields of the Influenza Vaccine Order Form for the UIIP must be completed to ensure orders are filled.

    Important Notes:

    Program Specific Information for the Various UIIP Participants

    Additional Resources and Information

    Questions

    For More Information

    Please e-mail uiip.moh@ontario.ca or call Service Ontario, INFOline at 1 877-844-1944